Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Dermacyd PH_DETINBACK · 2 trials · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Dermacyd PH\_DETINBACK (Lactic Acid) |
| Name | Type | Description |
|---|---|---|
| Dermacyd PH_DETINBACK (Lactic Acid) | DRUG | - |
Inclusion criteria: * Phototype Skin II and III; * Integral skin test in the region; * Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion; Exclusion criteria: * Lactation or gestatio...
Dermacyd PH_DETINBACK is a small molecule product developed by Sanofi for hygiene purposes. It is being studied in healthy female volunteers aged 18 years and older in Brazil. The product contains lactic acid and is intended for hygiene-related applications.
Dermacyd PH_DETINBACK is developed by Sanofi, a global pharmaceutical company listed on the stock exchange under the ticker SNY. Sanofi is conducting clinical trials for this hygiene product in Brazil.
Dermacyd PH_DETINBACK is in Phase 3 clinical development. Two Phase 3 trials have been completed, both involving healthy female volunteers. The product is investigational and has not been reported as approved for marketing.
Dermacyd PH_DETINBACK has two completed Phase 3 trials: NCT00785681, a compatibility study with 53 participants, and NCT00785720, a photo evaluation study with 26 participants. Both trials were conducted in Brazil with healthy female volunteers aged 18 years and older.
Dermacyd PH_DETINBACK contains lactic acid as its active ingredient, as indicated in the clinical trial titles. The product is being studied for hygiene applications, and the trials focus on compatibility and photo evaluation in healthy female volunteers.